Chemical Intermediate CAS 135-07-9 API Methyclothiazide

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 90/kg
Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Fast Delivery
The supplier can deliver the goods within 15 days
Low MOQ
The MOQ for the supplier's products is 1
to see all verified strength labels (7)
  • Chemical Intermediate CAS 135-07-9 API Methyclothiazide
  • Chemical Intermediate CAS 135-07-9 API Methyclothiazide
  • Chemical Intermediate CAS 135-07-9 API Methyclothiazide
  • Chemical Intermediate CAS 135-07-9 API Methyclothiazide
  • Chemical Intermediate CAS 135-07-9 API Methyclothiazide
  • Chemical Intermediate CAS 135-07-9 API Methyclothiazide
Find Similar Products

Basic Info.

Model NO.
HB-Methyclothiazide
Suitable for
Elderly, Children, Adult
State
Powder
Purity
≦96%
Appearance
White Powder
Sample
Available
Storage
Cool Dry Place
Shelf Life
2 Years
Transport Package
25kg/Drum
Specification
99%
Trademark
Haibo
Origin
China
HS Code
0000
Production Capacity
5000kg/Month

Product Description

Chemical Intermediate CAS 135-07-9 API MethyclothiazideChemical Intermediate CAS 135-07-9 API Methyclothiazide
Methyclothiazide, with the chemical name of 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazin-7-sulfonamide-1,1-dioxide, is an organic compound, with the chemical formula of C7H8ClN3O4S2, which is a thiazide diuretic compound.

1. Edematous disease: excrete excessive sodium and water in the body, reduce the volume of extracellular fluid, and eliminate edema. Common causes include congestive heart failure, cirrhosis and ascites, nephrotic syndrome, acute and chronic nephritis and edema, early chronic renal failure, sodium and water retention caused by adrenocortical hormone and estrogen treatment.
2. Hypertension: It can be used alone or in combination with other antihypertensive drugs, mainly for the treatment of primary hypertension.
3. Central or renal diabetes insipidus.
4. Nephrolithiasis: mainly used to prevent the formation of stones containing calcium salts.
5. It can also be used to relieve symptoms of frequent urination, urgency, and pain caused by urinary tract infections.

Chemical Intermediate CAS 135-07-9 API Methyclothiazide
Chemical Intermediate CAS 135-07-9 API Methyclothiazide
Chemical Intermediate CAS 135-07-9 API Methyclothiazide
Chemical Intermediate CAS 135-07-9 API Methyclothiazide
Analysi Specifications
Assay ≥99%
Appearance White powder
Loss on Drying ≤1.0%
Ash ≤1.0%
As ≤2.0ppm
Pb ≤2.0ppm
Insoluble impurity content ≤0.05%
Total Plate Count ≤1000 cfu/g
Yeast &. Mold ≤100 cfu/g
E.Coli Negative
Salmonella Negative
Conclusion
 
Conform USP Standard.
Storage condition
Store in cool & dry place, Keep away from strong light and heat.
Shelf life
2 years when properly stored.
Chemical Intermediate CAS 135-07-9 API MethyclothiazideChemical Intermediate CAS 135-07-9 API MethyclothiazideChemical Intermediate CAS 135-07-9 API MethyclothiazideChemical Intermediate CAS 135-07-9 API MethyclothiazideChemical Intermediate CAS 135-07-9 API MethyclothiazideChemical Intermediate CAS 135-07-9 API MethyclothiazideChemical Intermediate CAS 135-07-9 API Methyclothiazide
Chemical Intermediate CAS 135-07-9 API MethyclothiazideChemical Intermediate CAS 135-07-9 API MethyclothiazideChemical Intermediate CAS 135-07-9 API MethyclothiazideChemical Intermediate CAS 135-07-9 API Methyclothiazide

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier